Company Profile

Jinghua Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers active pharmaceutical ingredients (APIs) and intermediates, chemical and pharmaceutical intermediates, Chinese medicinal herbs and materials, health products, and Western medicine products. It also provides Jidesheng antivenomous tablets, Nantong Wang's baby health pill, Ningning ZhengChaihu granules, Dachaihu granules, Gubenkechuan tablets, dizziness treatment syrup, and Jinqiaomai tablets; and APIs, such as phenobarbital, primidone, fluorouracil, phenylbutazone, flucytosine, piroxicam, tenoxicam, and propylthiouracil. In addition, the company engages in enterprise management; technical services; goods and technology import and export; chemical wholesale; pharmaceutical retail; medical devices equipment sales; provision of cosmetics and skincare products; and investment activities. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is headquartered in Nantong, China.